药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Arsenic trioxide.
Tazarotene
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Arsenic trioxide.
Tazarotene
Benidipine
The risk or severity of QTc prolongation can be increased when Benidipine is combined with Arsenic trioxide.
Tazarotene
Melperone
The risk or severity of QTc prolongation can be increased when Melperone is combined with Arsenic trioxide.
Tazarotene
Lenvatinib
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Arsenic trioxide.
Tazarotene
Ceritinib
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Arsenic trioxide.
Tazarotene
Butriptyline
The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Arsenic trioxide.
Tazarotene
Eperisone
The risk or severity of QTc prolongation can be increased when Eperisone is combined with Arsenic trioxide.
Tazarotene
Fendiline
The risk or severity of QTc prolongation can be increased when Fendiline is combined with Arsenic trioxide.
Tazarotene
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Arsenic trioxide.
Tazarotene
Crizotinib
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Arsenic trioxide.
Tazarotene
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Arsenic trioxide.
Tazarotene
Nilvadipine
The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Arsenic trioxide.
Tazarotene
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Arsenic trioxide.
Tazarotene
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Arsenic trioxide.
Tazarotene
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Arsenic trioxide.
Tazarotene
Tedisamil
The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Arsenic trioxide.
Tazarotene
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Arsenic trioxide.
Tazarotene
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Arsenic trioxide.
Tazarotene
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Arsenic trioxide.